Evidence map›Paper›PMID 33768318›Full record

ArticleVirchows Archiv : an international journal of pathology2021

High performance of multiplex fluorescence in situ hybridization to simultaneous detection of BCL2 and BCL6 rearrangements: useful application in the characterization of DLBCLs.

Federica Zito Marino, Gabriella Aquino, Matteo Brunelli, Giosuè Scognamiglio, Serena Pedron, Andrea Ronchi, Immacolata Cozzolino, Lucianna Sparano, Gerardo Botti, Luigi Panico and 3 more

Open access · hybridAbstract readValidation Study
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Federica Zito MarinoPathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania "L Vanvitelli", Via Luciano Armanni, 5, 80138, Naples, Italy.
Gabriella AquinoPathology Unit, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Via Mariano Semmola, Naples, Italy.
Matteo BrunelliPathology Unit, Department of Pathology and Diagnostics, University and Hospital Trust of Verona, P.le L.A. Scuro n. 10, 37134, Verona, Italy.
Giosuè ScognamiglioPathology Unit, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Via Mariano Semmola, Naples, Italy.
Serena PedronPathology Unit, Department of Pathology and Diagnostics, University and Hospital Trust of Verona, P.le L.A. Scuro n. 10, 37134, Verona, Italy.
Andrea RonchiPathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania "L Vanvitelli", Via Luciano Armanni, 5, 80138, Naples, Italy.
Immacolata CozzolinoPathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania "L Vanvitelli", Via Luciano Armanni, 5, 80138, Naples, Italy.
Lucianna SparanoPathology Unit, 'Andrea Tortora' Hospital, Via Andrea Tortora, 84016, Pagani, Salerno, Italy.
Gerardo BottiPathology Unit, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Via Mariano Semmola, Naples, Italy.
Luigi PanicoPathology Unit, Monaldi Hospital, Via Leonardo Bianchi, 80131, Avellino, Italy.
Anna De ChiaraPathology Unit, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Via Mariano Semmola, Naples, Italy.
Renato FrancoPathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania "L Vanvitelli", Via Luciano Armanni, 5, 80138, Naples, Italy. RENATO.FRANCO@unicampania.it.
Gruppo Ematopatologia Campano
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Verona · ITCTO Andrea Alesini · ITOspedale Monaldi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromosomal rearrangements involving BCL2, BCL6 and MYC are commonly found in the most frequent B cell lymphomas, namely follicular lymphomas (FLs) and diffuse large B-cell lymphomas (DLBCLs). Particularly, BCL2-rearrangement represents a diagnostic hallmark in FLs, whereas MYC translocation can occur simultaneously with BCL2 and/or BCL6 rearrangements, defining a specific category of DLBCLs with a poorer prognosis. In this study, we aim to validate the diagnostic performance of multiplex BCL2/BCL6 FISH approach in formalin-fixed paraffin-embedded FLs and DBCLs and cytological samples of DLBCL comparing to the classic set of single break-apart probes. We collected a series of lymphomas, including 85 DLBCLs, 45 FLs and 36 other B-cell lymphoma histotypes and 16 cytological samples of DLBCLs. MYC, BCL2 and BCL6 rearrangements were previously assessed by a classic FISH test using single break-apart probes. All samples were analysed by a multiplex FISH assay. In the FL series, 38 cases showed BCL2-R; in the DLBCLs series, MYC-R was detected in 21 out of 85 DLBCL patients, BCL2-R in 10 out of 85 and BCL6-R in 33 out of 85. In the DLBCL cytological series, MYC-R was detected in 4 out of 16, BCL2-R in 4 out of 16 and BCL6-R in 1 out of 16. Notably, in FFPE, 13 double-hit lymphomas (DHLs) and 3 triple-hit lymphomas (THLs) were detected; in the cytological series, only 3 DHL cases were observed. The dual BCL2/BCL6 FISH probe test results were fully concordant with the results obtained using classic BCL2 and BCL6 single break apart. Particularly, multiplex FISH to simultaneously detect BCL2-R and BCL6-R on a single slide could find a wide application in the characterisation of double- and triple-hit DLBCLs.

Indexed as

Gene RearrangementIn Situ Hybridization, FluorescenceAdultAgedAged, 80 and overBiomarkers, TumorFemaleGenetic Predisposition to DiseaseHumansLymphoma, Large B-Cell, DiffuseMaleMiddle AgedPhenotypePredictive Value of TestsProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-bcl-6BCL2 protein, humanBCL6 protein, humanBiomarkers, TumorProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-bcl-6BCL2 rearrangementsBCL6 rearrangementsDiffuse large B-cell lymphoma (DLBCL)Fluorescence in situ hybridisation multiprobe BCL2/BCL6Multiplex fluorescence in situ hybridisationMYC rearrangements

Identifiers

PMID33768318
PMCPMC8448700
OpenAlexW3138311989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.